Prednisone/cyclophosphamide treatment in adult-onset autosomal dominant familial focal segmental glomerulosclerosis (FSGS 1).
Grcevska
L
L
Dzikova
S
S
Petrusevska
G
G
Polenakovic
M
M
D000284:Administration, Oral; D000328:Adult; D017668:Age of Onset; D025063:Chromosome Disorders / Q000188:drug therapy; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000235:genetics; D009404:Nephrotic Syndrome / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy; D016896:Treatment Outcome
D003520:Cyclophosphamide; D003404:Creatinine; D011241:Prednisone